Sientra taps medtech vet Nugent for CEO

Embattled breast implant maker Sientra (NSDQ:SIEN) said yesterday that it tapped medical device and pharmaceutical industry veteran Jeffrey Nugent to be its chairman & CEO, effective immediately. Nugent, older brother to musician and gun-rights activist Ted Nugent, replaces CEO Hani Zeini and chairman Nicholas Simon, both of whom are slated to retain their seats on the board. Nugent was the founder and CEO of Precision Dermatology, which was acquired by Valeant Pharmaceuticals (NYSE:VRX) last year. Last July he stepped down from the interim CEO role at Biolase (NSDQ:BIOL), after taking over from Federico Pignatelli, who was forced to retire after a feud with major stakeholder Oracle Partners. Sientra last month put a temporary hold on U.S. sales of implants made by Brazilian contract manufacturer Silimed, after Brazilian regulator Anvisa and the U.K.’s Medicines & Healthcare Products Regulatory Agency had already suspended sales after contamination was detected during an audit of the company’s manufacturing practices. In late October Zeini said there’s no timeline on getting the implants back on the market. “Jeff is a leader whose record shows a relentless focus on execution and high performance, and we are fortunate to have an executive of his caliber to take Sientra forward. Jeff’s decades of experience leading companies in the pharmaceuticals and medical device industry and intimate knowledge of the company make him uniquely qua...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Cosmetic/Aesthetic Wall Street Beat Personnel Moves Sientra Source Type: news